Synthesis of Cholesterol and Bile Salts/Acids Flashcards
1
Q
Influx and Efflux of Liver Cholesterol
A
- the liver plays an essential role in maintaing human cholesterol homeostasis
- the sources of the liver’s cholesterol pool include dietary cholesterol and that synthesized de novo by extrahepatic tissues and the liver itself
- cholesterol leaves the liver as unmodified free cholesterol in the bile, or by conversion to bile acids/salts secreted into the intestinal lumen, or as VLDL secreted into the circulation
- the balance of influx and efflux is not perfect and can lead to a deposition of cholesterol in the endothelial lining of blood vessels
2
Q
Cholesterol Sturcture
A
- four planar hydrocarbon rings called the steroid nucleus
- it has an eight carbon hydrocarbon attached to carbon 17, of the D ring; a hydroxyl group attached to carbon 3 of the A ring; and a double bond between carbon 5 and 6 of the B ring
- most cholesterol in the plasma is esterified to a fatty acid at carbon 3. The cholesteryl ester is even more hydrophobic than cholesterol itself
3
Q
Cholesterol and Cell membranes
A
- sterols appear to have evolved to fill the flickering spaces between the fatty acyl chains in membrane bilayers
- the hydroxyl group of cholesterol gives the otherwise hydrophobic molecule its amphiphilic character
- the steroid rings and hydrocarbon tail intercalate between the fatty acid chain of the phospholipids, within the membrane bilayer, while the polar OH group is in line with the polar head groups and in contact with the aqueous environment
- at physiologic conditions cholesterol increases the packing within the hydrophobic core of the bilayer, thereby increasing the mechanical strength while decreasing the permeability and fluidity of the membrane
4
Q
Sterols
A
- cholesterol is the major form in animal tissues of a family of molecules called sterols
- contain four fused hydrocarbon rings, 8 to 10 carbon atoms in the hydrocarbon tail attached to carbon 17 and a hydroxyl group at carbon 3
- while ~40% of dietary cholesterol is absorbed by humans only 5% of plant sterols are absorbed
- Beta-sitosterol, a plant sterol, and excess cholesterol upon entering the enterocytes is actively transported back into the intestinal lumen by two members of the ATP Binding Cassette family of transporters
- when either transporter is defective that causes the rare autosomal recessive condition of sitosterolemia
- the accumulated Beta-sitosterol and cholesterol in the enterocytes eventually enter the blood stream Sitosterolemia
- this explains the increased cardiovascular morbidity in people with this disorder
- the drug ezetimbe blocks cholesterol intestinal absorption through the enterocyte brush border
5
Q
Cholesterol Basics
A
- cholesterol is synthesized by virtually all cells, except RBCs, in the human
- the majority is synthesized by the liver, intestines, adrenal cortex and reproductive tissues
- similar to fatty acid synthesis all carbons in cholesterol are provided by acetyl CoA and NADPH provides the reducing equivalents
- the pathway requires energy that is supplied by hydrolysis of the thioester bond of acetyl CoA and the terminal phosphate of ATP
- the reactions occur on the cytoplasmic surface of the smooth ER and require ER membrane and cytosolic enzymes
6
Q
Acetyl CoA to HMG CoA
A
- first two molecules of acetyl coA condense, with loss of one CoA, to form Acetoacetyl CoA
- a third molecule of acetyl coA is added by HMG-CoA synthase forming 3-Hydroxy-3-methylglutaryl (HMG) CoA
- the cytosolic form of HMG-CoA synthase, not the mitochondrial isoenzyme, catalyzes this reaction
7
Q
HMG CoA to Mevalone
A
- key regulatory step
- the next rate limiting and key regulatory step, in the synthesis of cholesterol, is the conversion of HMG CoA to mevalonate
- the reaction is catalyzed by HMG CoA reductase
- the reaction requires 2 molecules of the NADPH as the reducing agent
- CoA is released making the reaction irreversible
- the enzyme is an integral membrane protein of the smooth ER with a catalytic domain facing the cytoplasm
- there is inhibition of enzyme expression by excess cholesterol
8
Q
Mevalonate to Cholesterol
A
- mevalonate is converted to 5-pyrophosphomevalonate in two steps each of which transfers a phosphate group from ATP
- a five carbon isoprene unit, isopentenyl pyrophosphate (IPP), is formed by the decarboxylation of 5-pyrophosphomevalonate. The reaction requires ATP. IPP is the precursor of a family of molecules, the isoprenoids. Cholesterol is a sterol isoprenoid. Nonsterol isoprenoids include dolichol, coenzyme Q and vitamin K
- IPP is isomerixed to 3,3-dimethylallyl phosphosphate (DPP)
- IPP and DPP condense to form ten-carbon geranyl pyrophosphate (GPP)
- a second molecule of IPP then condenses with GPP to form 15- carbon farnesyl pyrophosphhate (FPP). Covalent attachment of farnesyl to proteins, a process known as prenylation is one mechanism for anchoring proteins to plasma membranes
- two molecules of FPP combine, releasing pyrophosphate, and are reduced forming the 30-carbon compound squalene. Squalene is formed from six isoprenoid units (takes 18 ATP)
- squalene is converted to the sterol lanosterol by a sequence of reactions catalyxed by ER associated enzymes that use molecular oxygen and NADPH. The hydroxylation of squalene triggers the cyclization of the structure to lanosterol
- conversion of lanosterol to cholesterol is a multistep, ER-associated process involving shortening of the side chain, oxidative removal of methyl groups, reduction of double bonds and migration of double bond
9
Q
Smith-Lemli-Opitz Syndrome
A
- an autosomal recessive disorder of choleterol biosynthesis, iscaused by a partial deficiency of 7-dehydrocholesterol-7-reductase, the enzyme that reduces the double bond in 7-dehydrocholesterol (7-DHC) thereby converting it to cholesterol
- SLOS is one of several multisystem, embryonic malformation syndrome associated with impaired cholesterol synthesis
10
Q
Regulation of HMG CoA Reductase
A
- expression of the HMG CoA Reductase gene is under the control of a transcription factor SREBP-2 which binds the cis acting sterol regulatory element. SREBP-2, in its inactive form, is an integral ER membrane protein
- it associates with another ER protein SCAP
- when cholesterol levels are low the SREBP-2-SCAP complex moves to the Golgi where it stimulates specific cleavage of SREBP resulting in a soluble fragment that is activated SREBP transcription factor
- the SREBP transcription factor enters the nucleus, binds SRE and stimulates the expression of HMG CoA reductase mRNA transcripts, increasing expression of the enzyme and cholesterol synthesis
- when cholesterol is at high concentration it binds to the sterol sensing domain of SCAP, which binds to additional ER proteins (insigs, insulin induced gene products) which anchor the SREBp-2-SCAP complex to the ER membrane. As a result cholesterol synthesis decreases
11
Q
Enzyme Degradation of HMG CoA reductase
A
- when cholesterol levels are high they also bind to the sterol-sensing domain of the reductase itself
- this causes binding of the reductase to insigs in the ER membrane which triggers ubiquitination and proteasomal degradation of the enzyme, leading to reduced cholesteol biosynthesis
12
Q
Phosphorlyation/Dephosphorylation of HMG CoA reductase
A
- the reductase is controlled by AMP-activated protein kinase and a phosphoprotein phosphatase
- the phosphorylated form of enzyme is inactive and the dephosphorylated form is active
- when ATP is low, and AMP high the enzyme is inactive and cholesterol synthesis is reduced
13
Q
Hormones HMG CoA reductase
A
-insulin and thyroxine upregulate expression of the HMG CoA reductase gene while glucagon and glucocorticoids down regulate expression
14
Q
Statin Drugs
A
-portions of statins clearly resemble HMG CoA. However the bulky hydrophobic groups of the inhibitors differ from the CoA moiety of the substrate
- they can serve as competitive inhibitors of HMG CoA Reductase
- they lower plasma levels of cholesterol
15
Q
Degradation of Cholesterol
A
- the ring structure of cholesterol is not metabolized to CO2 and water in humans
- the Sterol Nucleus is eliminated from the body by conversion to bile acids and bile salts
- a small percentage of cholesterol is eliminated in the feces or by secretion into the bile which carries it to the intestine for elimination
- some of the cholesterol in the intestine is modified by bacteria before excretion
- the primary products made are isomers of coprostanol and cholestanol, reduced forms of cholesterol
- the two compounds above and cholesterol make up a majority of neutral fecal sterols